IGF1-DES 1-3 – Pharmaqo Labs

IGF1-DES 1-3 Pharmaqo Labs for sale in the UK

IGF1-DES 1-3 by Pharmaqo Labs is a truncated IGF-1 peptide used by advanced bodybuilders for site-specific muscle development around a working set, rather than as a systemic anabolic. If you want to buy IGF-1 DES UK from a verified source, each batch sold here is lab-tested and shipped same working day from our UK warehouse.

What is IGF-1 DES (1-3)?

IGF-1 DES (1-3) is a synthetic IGF-1 analogue in which the first three amino acids have been removed from the N-terminus of native insulin-like growth factor-1. That single structural change has two consequences: it dramatically reduces affinity for IGF binding proteins, leaving more free peptide available at the receptor, and it produces a fragment reported to have roughly 10× the site-specific potency of full-length IGF-1 LR3 at the injection site. Active half-life is very short — around 20–30 minutes — so DES does not behave like a systemic anabolic. Instead it is used as a localised, pre-workout signalling tool that pushes IGF-1 receptor activation, satellite-cell recruitment and protein synthesis in the specific muscle worked during the session.

IGF1-DES 1-3 benefits

• Site-specific muscle development — work the lagging body part, inject the same area
• Promotes satellite-cell activation and hyperplasia signalling
• Enhanced glucose uptake and nutrient partitioning into trained tissue
• Supports recovery and repair around heavy training sessions
• No aromatisation, no HPTA suppression, no oral liver load

The very short half-life is a feature, not a flaw: DES 1-3 is intended to flood the trained muscle for one session and then clear, which is why it sits beside (not in place of) longer-acting peptides like IGF-1 LR3 or HGH.

IGF1-DES 1-3 dosage and cycle

Beginners: 50 mcg per session. Intermediate: 75–100 mcg per session. Advanced: 100–150 mcg per session. Cycle length typically runs 4–6 weeks. Inject intramuscularly directly into the trained muscle pre-workout; for bilateral body parts split the dose between both sides. Reconstitute the lyophilised vial with bacteriostatic water and use the solution promptly — DES is unstable once reconstituted and is best treated as a same-session product.

Side effects and harm reduction

The dominant practical risk is hypoglycaemia: IGF-1 receptor activation increases glucose uptake into muscle and can drop blood sugar quickly, especially on an empty stomach. Always carry fast-acting carbohydrates (glucose tabs, juice or sweets) and dose around food, not on an empty stomach. Other reported effects include mild headaches during the first sessions, transient injection-site irritation and, with chronic high doses, theoretical concerns about visceral and connective-tissue growth. There is no aromatisation, no androgenic acne or water retention, and no liver load — DES does not require an aromatase inhibitor or PCT, but anyone running it alongside AAS should still follow standard cycle-support protocols.

Stacks well with

IGF-1 DES 1-3 is most often run alongside a longer-acting peptide for combined systemic and site-specific effect. Many users pair it with IGF-1 LR3 on training days, add Qomatropin HGH 100IU as a baseline growth-hormone driver, or run MK-677 at bedtime to keep nocturnal GH and IGF-1 elevated. A syringe, needle and swab pack plus bacteriostatic water covers the full reconstitution and injection setup.

Frequently asked questions

How long does IGF1-DES 1-3 take to start working?

Acute receptor effects begin within minutes of injection — that is why DES is dosed pre-workout directly into the muscle being trained. Visible changes in muscle fullness and pump are typically reported during the first session, with cumulative changes in trained-area development building over a 4–6 week run.

Is IGF1-DES 1-3 suitable for first-time users?

Not really. DES is an advanced peptide that assumes confident intramuscular injection, peptide reconstitution and basic blood-glucose awareness. First-time peptide users are usually better served starting with IGF-1 LR3 or MK-677, which are more forgiving on dosing and timing, before progressing to a site-specific tool like DES 1-3.

Can IGF1-DES 1-3 be detected on a drug test?

Standard urine GC-MS panels used in workplace and most sport testing do not screen for IGF-1 DES specifically. WADA-accredited laboratories can detect IGF-1 axis manipulation through advanced biomarker profiling, so any tested athlete should treat DES as a prohibited substance regardless of the panel in front of them.